A phase III study of active surveillance therapy against radical treatment in patients diagnosed with favourable risk prostate cancer (START)

• Country Australia, Canada, New Zealand, United States of America
• organs None
• Specialty None

A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia with a Focus on Patients with Infections Due to Methicillin-Resistant Staphylococcus aureus (ATTAIN I & ATTAIN II)

• Country Australia, United States of America
• organs None
• Specialty None

Trial of PI-88 with Dacarbazine in patients Metastatic Melanoma

• Country Australia, United States of America
• organs None
• Specialty None

Evaluating the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology

• Country Australia, France, Germany, Italy, Poland, United Kingdom, United States of America
• organs None
• Specialty None

DORADO-AC-EX – A Double-Blind, Active-Controlled, Long-Term Safety Extension Study to the Phase 3 DORADO-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension

• Country United States of America
• organs None
• Specialty None

Study of VX-770 in Cystic Fibrosis Subjects

• Country Australia, Canada, Czech Republic, France, Germany, Ireland, United Kingdom, United States of America
• organs None
• Specialty None

PHX1149 in Patients With Type 2 Diabetes Mellitus

• Country United States of America
• organs None
• Specialty None

The use of tiagabine and gabapentin in the treatment of social anxiety disorder in 8 patients

• Country United States of America
• organs None
• Specialty None

Group Schema Therapy for Borderline Personality Disorder

• Country Australia, Germany, Netherlands, United Kingdom, United States of America
• organs None
• Specialty None

Safety and Efficacy Study of Oral IFN-tau in Patients with Relapsing-Remitting Multiple Sclerosis

• Country United States of America
• organs None
• Specialty None